Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
Authors
Keywords
-
Journal
NATURE BIOTECHNOLOGY
Volume 36, Issue 9, Pages 857-864
Publisher
Springer Nature America, Inc
Online
2018-08-13
DOI
10.1038/nbt.4222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
- (2017) Cristina Romani et al. NEUROPSYCHOLOGY
- Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
- (2017) In Young Hwang et al. Nature Communications
- Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47
- (2017) Jacob D. Palmer et al. ACS Infectious Diseases
- Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria
- (2017) Sean M. Bell et al. PLoS One
- Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU
- (2017) Katherine E. Durrer et al. PLoS One
- Structure-Function Relationships in l-Amino Acid Deaminase, a Flavoprotein Belonging to a Novel Class of Biotechnologically Relevant Enzymes
- (2016) Paolo Motta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two-Step Production of Phenylpyruvic Acid from L-Phenylalanine by Growing and Resting Cells of Engineered Escherichia coli: Process Optimization and Kinetics Modeling
- (2016) Ying Hou et al. PLoS One
- Genetically Engineered Escherichia coli Nissle 1917 Synbiotics Reduce Metabolic Effects Induced by Chronic Consumption of Dietary Fructose
- (2016) Chaudhari Archana Somabhai et al. PLoS One
- Production of phenylpyruvic acid from l-phenylalanine using an l-amino acid deaminase from Proteus mirabilis: comparison of enzymatic and whole-cell biotransformation approaches
- (2015) Ying Hou et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Long-term safety and efficacy of sapropterin: The PKUDOS registry experience
- (2015) Nicola Longo et al. MOLECULAR GENETICS AND METABOLISM
- Biocontainment of genetically modified organisms by synthetic protein design
- (2015) Daniel J. Mandell et al. NATURE
- Programmable probiotics for detection of cancer in urine
- (2015) Tal Danino et al. Science Translational Medicine
- Phenylalanine hydroxylase deficiency: diagnosis and management guideline
- (2014) GENETICS IN MEDICINE
- Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy
- (2014) Nicola Longo et al. GENETICS IN MEDICINE
- Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
- (2014) Zhongyi Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- GeneGuard: A Modular Plasmid System Designed for Biosafety
- (2014) Oliver Wright et al. ACS Synthetic Biology
- Building-in biosafety for synthetic biology
- (2013) O. Wright et al. MICROBIOLOGY-SGM
- Psychiatric symptoms in adults with phenylketonuria
- (2013) Deborah A. Bilder et al. MOLECULAR GENETICS AND METABOLISM
- Synthetic Biology Moving into the Clinic
- (2011) W. C. Ruder et al. SCIENCE
- Translational Regulation of Gene Expression by an Anaerobically Induced Small Non-coding RNA in Escherichia coli
- (2010) Anders Boysen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reprogramming of anaerobic metabolism by the FnrS small RNA
- (2010) Sylvain Durand et al. MOLECULAR MICROBIOLOGY
- Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers
- (2009) Thai Hoa Joeres-Nguyen-Xuan et al. INFLAMMATORY BOWEL DISEASES
- Pathogenesis of cognitive dysfunction in phenylketonuria: Review of hypotheses☆
- (2009) M.J. de Groot et al. MOLECULAR GENETICS AND METABOLISM
- Dietary Guidelines should reflect new understandings about adult protein needs
- (2009) Donald K Layman Nutrition & Metabolism
- Clinical use of E. coli Nissle 1917 in inflammatory bowel disease
- (2008) Michael Schultz INFLAMMATORY BOWEL DISEASES
- Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria
- (2008) C. N. Sarkissian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now